Skip to content

A Randomized, Placebo Controlled, Single-blinded Clinical Trial to Evaluate the Efficiency of Autologous Adipose Stem Cell in Promoting Skin Graft

A Randomized, Placebo Controlled, Single-blinded Clinical Trial to Evaluate the Efficiency of Autologous Adipose Stem Cell in Promoting Skin Graft

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037456
Enrollment
Unknown
Registered
2020-08-28
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin graft for skin defect repair

Interventions

Experimental versus Control group:Adipose stem cell versus Traditional skin grafts transplant surgery

Sponsors

Shanghai Jiao Tong University, School of Medicine, Shanghai Ninth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 6-70 years old male and female; 2. Scar, surface tumor or soft tissue defect evaluated to be suitable for skin grafting; 3. With two skin grafting areas and the edges more than 4cm apart; 4. Sign informed consent, participate in the study and be able to cooperate with the follow-up.

Exclusion criteria

Exclusion criteria: 1. Those who are not suitable for skin grafting; 2. There who are with local lesions in the operation area, such as infection, blood supply disturbance, delayed healing history, decreased soft tissue vitality, history of radiotherapy or going to receive radiotherapy, active ulcer, etc; 3. With severe medical diseases (such as diabetes, hepatitis, coronary heart disease, arteriosclerosis, glomerulonephritis, autoimmune diseases, etc.) were complicated; 4. Those who are receiving anticoagulant therapy and cannot suspend treatment; 5. Those who are with abnormal blood routine test, abnormal coagulation function, abnormal cardiac function, abnormal liver function or renal function evaluated by researchers according to the laboratory examination and other clinical signs and symptoms; 6. Those who can't tolerate the operation risk according to the surgeon's evaluation; 7. Pregnant and lactating women; 8. Those who have mental illness, have no insight, can not express and cooperate with each other; 9. Participant in other clinical trials within 30 days before the screen visit of this trial; 10. Those who have not signed the informed consent.

Design outcomes

Primary

MeasureTime frame
Skin elasticity;

Secondary

MeasureTime frame
Skin color;Skin elasticity;POSAS questionnaire of patient;POSAS questionnaire of investigator;

Countries

China

Contacts

Public ContactQing-Feng Li

Shanghai Jiao Tong University, School of Medicine, Shanghai Ninth People's Hospital

dr.liqingfeng@yahoo.com+86 021-23271699-5615

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026